JPRN-UMIN000002665
Completed
未知
Comparative study of high-dose ciclesonide and fluticasone on small airway in asthmatics - Comparison of ciclesonide and fluticasone on small airway in asthmatics
Kurume University School of Medicine0 sites18 target enrollmentOctober 25, 2009
Conditionsasthma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- asthma
- Sponsor
- Kurume University School of Medicine
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Inhaled, oral and injective corticosteroids, leukotriene receptor antagonists, inhaled, oral and transdermal long acting beta2 agonists,sodiumchromoglicate, xanthine, immunosuppressive agents, and anti\-allergic agents (include anti\-IgE antibody) is used 4wks prior to screening. 2\. Respiratory infections (within 4wks) 3\. Other underlying diseases 4\. Any psychological disease 5\. Pregnacy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Ciclesonide comparison with fluticasone in mild persistent asthmaAsthma.Asthma, unspecifiedIRCT201201028597N1Massih Daneshvari hospital356
Active, not recruiting
Not Applicable
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) - RAINBOWAsthma bronchialMedDRA version: 8.1Level: LLTClassification code 10003555Term: Asthma bronchialEUCTR2006-000803-40-DEycomed GmbH1,050
Active, not recruiting
Phase 1
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW)Estudio comparativo de ciclesonide inhalado frente a placebo en niños con asma - RAINBOWAsthma bronchialAsma bronquial persistenteMedDRA version: 9.0Level: LLTClassification code 10003555EUCTR2006-000803-40-ESALTANA Pharma AG1,080
Active, not recruiting
Not Applicable
A comparative study of inhaled ciclesonide versus placebo in children with asthma (RAINBOW) - RAINBOWEUCTR2006-000803-40-HUALTANA Pharma AG1,050
Active, not recruiting
Phase 1
Effect of Ciclesonide (320 µg/day) vs. Fluticasone Propionate (375 µg/day) vs. Placebo on Short-term Linear Growth Rate and HPA-axis Function in Prepubertal Children with Mild AsthmaA double-blind, double-dummy, placebo-controlled, randomized, 3 period cross-over studyasthma bronchialeMedDRA version: 5.1Level: lltClassification code 10003553EUCTR2005-001386-34-DKALTANA Pharma AG